Skin Carcinoma
15
2
5
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.3%
2 terminated out of 15 trials
77.8%
-8.7% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
Cancer Genetic Testing in Ethnic Populations
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers
SMART Project in Preventing Skin Cancer
Itch and Pain Characteristics in Skin Carcinomas
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule